Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%



  • Chardan Capital boosted the price target on Intellia Therapeutics, Inc. NTLA from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.

  • Stifel cut Neoleukin Therapeutics, Inc. NLTX price target from $14 to $0.9. Neoleukin Therapeutics shares fell 1.9% to close at $0.5301 on Monday.

  • Raymond James cut Cambium Networks Corporation CMBM price target from $29 to $26.. Cambium Networks shares rose 2.4% to close at $22.83 on Monday.

  • Piper Sandler slashed the price target on Motus GI Holdings, Inc. MOTS from $10 to $6. Motus GI Holdings shares rose 0.5% to close at $1.87 on Monday.

  • Oppenheimer cut the price target for Gamida Cell Ltd. GMDA from $15 to $10. Gamida Cell shares gained 1.5% to $2.00 in pre-market trading.

  • SVB Leerink raised the price target on Roivant Sciences Ltd. ROIV from $7 to $8. Roivant Sciences shares gained 2.5% to close at $5.29 on Monday.

  • Barclays cut the price target for Joby Aviation, Inc. JOBY from $6 to $4.5. Joby Aviation shares gained 3.5% to $4.47 in pre-market trading.





Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!